We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Healthcare Inv | LSE:HIO | London | Ordinary Share | GB00B94T6Y14 | ORD 1P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 14.75 | 0.00 | 00:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMCOS
Collagen Solutions PLC
20 February 2017
Collagen Solutions Plc
(the "Company" or the "Group")
Investor Presentation
Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, announces that the Company will host an afternoon presentation for investors on Monday, 20 March 2017. Jamal Rushdy, CEO of the Company, will give an update on news, including the strategy behind the recent placing and open offer.
The event will take place in the Black Bar, upstairs at Rocket Bar, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.30pm for a 4.45pm start.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.
Enquiries:
Collagen Solutions Plc Contact via Walbrook Jamal Rushdy, Chief Executive Officer Gill Black, Chief Financial Officer Cenkos Securities plc (Nominated Tel: 0207 397 8900 Adviser and Broker) Stephen Keys Steve Cox Walbrook PR Tel: 020 7933 8780 or collagen@walbrookpr.com Mike Wort Mob: 07900 608 002 Anna Dunphy Mob: 07876 741 001
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAGMGMZGNRGNZM
(END) Dow Jones Newswires
February 20, 2017 02:01 ET (07:01 GMT)
1 Year Healthcare Inv Chart |
1 Month Healthcare Inv Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions